Multiple sclerosis (MS) is the common demyelinating disease of human central nervous
system. Among mouse models available to study MS, including the cuprizone application …

We present an automated two-dimensional Fourier transform (2D-FT) approach to analyze
the local organization of myelinated axons in the spinal cord. Coherent anti-Stokes Raman …

Tolerogenic vaccines represent a new class of vaccine designed to re-establish
immunological tolerance, restore immune homeostasis, and thereby reverse autoimmune …

In various autoimmune diseases, anti-tumour necrosis factor (TNF)-α treatment has been
shown to reduce both clinical disease severity and T helper type 1 (Th1) 1/Th17 responses …

Identification of non-invasive biomarkers of disease progression in multiple sclerosis (MS) is
critically needed for monitoring the disease progression and for effective therapeutic …

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS that is
heterogeneous in its clinical manifestation and progression, as well as in its pathological …

Multiple Sclerosis (MS) is an incurable central nervous system (CNS) demyelinating disease
affecting several million people worldwide. Due to the multifactorial and complex pathology …

B cell depletion (BCD) is being considered as a treatment for multiple sclerosis (MS), but
there are many uncertainties surrounding the use of this therapy, such as its potential effect …

Multiple sclerosis (MS) is an autoimmune disease involving demyelination and axonal
damage in the central nervous system (CNS). In this study, we investigated pathological …

Multiple Sclerosis (MS) is a chronic and autoimmune disease of the central nervous system
that causes inflammation in the brain and spinal cord, progressive degeneration of central …